Advertisement
Home 2016 July

Monthly Archives: July 2016

A burst of moderate exercise may improve motivation and energy in adults with symptoms of attention-deficit/hyperactivity disorder

Burst of Moderate Exercise May Reduce Adult ADHD Symptoms

0
Activity won't replace standard treatments but could be helpful add-on
Recommendations have been updated for treatment of Helicobacter pylori in adults

Recommendations Updated for H. pylori Treatment in Adults

0
All regimens should be given for 14 days; first-line strategies include quadruple therapies PAMC, PMBT
An elderly resident of Utah who died at the end of June is the first fatality in the continental United States linked to infection with the Zika virus

Utah Resident Is First Zika-Linked Death in Continental U.S.

0
Patient had an underlying medical condition and tested positive for Zika
The ExAblate Neuro device has been approved by the U.S. Food and Drug Administration to deliver focused ultrasound to destroy tissue in a tiny area of the brain that is thought to be involved in essential tremor.

FDA Approves Ultrasound Device to Treat Essential Tremor

0
Focused ultrasound device to treat essential tremor in patients who have not responded to medication
The once-daily acne treatment Differin Gel 0.1% (adapalene) has been approved for over-the-counter use among patients 12 and older

FDA Approves Differin Gel for Over-the-Counter Use

0
First OTC retinoid available for acne treatment among patients 12 and older
As artificial infill surface weight decreases

AOSSM: High School Football Injuries Tied to Turf Composition

0
Researchers recommend minimum of 6.0 pounds per square foot of infill weight
Concussion rates are rising sharply among U.S. children and teens

AOSSM: Concussion Rates on the Rise in U.S. Youth

0
May be due to rise in youth sports participation, better diagnostic skills/training
Medication organization devices may cause medication-related adverse events in unintentionally nonadherent older people

Medication Organization Devices Tied to Adverse Effects

0
Study identifies design elements for future trials to evaluate device effectiveness in elderly
The U.S. Food and Drug Administration has approved Roche's cobas HPV Test as the first diagnostic to be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid.

Approval of First HPV Test for Use With SurePath Preservative Fluid

0
For cervical cells obtained for Pap test, collected in SurePath Preservative Fluid
Patients with T3 glottic squamous cell carcinoma have improved overall survival with surgical treatment versus nonsurgical management

Overall Survival Up With Surgical Treatment in T3 Glottic SCC

0
Improved OS for surgery alone, surgery with adjuvant treatment versus nonsurgical management